Search

ICASA offered US$100,000–$500,000 for 18–36-month antimicrobial-stewardship projects relevant to U.S. beef or swine production. Domestic and international organizations could apply, with matching funds covering at least 40% of the total bud

The Biotechnology Society of Tanzania announced its September Journal Club Session II featuring Dr Irene K. Lweikiza on bacteriophages in a One Health perspective, with applications in humans, animals and environmental health. The session w

Phage Team Uganda announced a symposium on capacity building for phage research and applications against AMR in human, animal, crop and environmental health, at School of Food Technology, Nutrition & Bioengineering Hall, Makerere University

HERA Invest offers non-dilutive venture loans covering up to 50% of investment costs for innovative SMEs developing medical countermeasures, including AMR technologies. Applications are accepted on a rolling basis. Applicants must already h

Belgian biotech Obulytix says it is developing Precision Lysin Therapeutics, engineered phage-derived enzymes that degrade bacterial cell walls, with a lead programme against multidrug-resistant Acinetobacter baumannii; it reports activity

Competition-funded PhD project in Dr Tatiana Dimitriu's group (with Prof M F White), School of Biology, University of St Andrews, through the EASTBIO Doctoral Training Partnership. It characterises the mechanism of lethal zygosis, where rec

The Czech medicines regulator SÚKL has granted consent to begin phase II B clinical evaluation of DUOFAG®. This follows completed phase I, which confirmed the product’s safety, and ongoing phase II A examining efficacy in patients with comp

Save the date: JAFRAL Phage Summit 2027, 20–22 May at Grand Hotel Union in Ljubljana, Slovenia. For the second edition, organizers plan more compassionate-use cases and patient stories, more poster presentations, and travel grants for early

One Health, One Solution brings together scientists, early-career researchers, clinicians, regulatory experts and industry professionals to discuss bacteriophage therapy against antimicrobial resistance. Via www.bits-pilani.ac.in. BITS Pil

Self-funded PhD project at the Queen’s University Belfast School of Pharmacy (Dr Timofey Skvortsov, Dr Sheiliza Carmali) to mine phage and prophage genomes for endolysins, depolymerases and receptor-binding proteins, engineer modular varian

BIRAC’s May 2025 biotechnology call covered BIPP, SBIRI and PACE’s AIR and CRS schemes, from proof-of-concept work to validation and pre-commercialisation. Its stated priorities included therapies for antimicrobial resistance, agriculture,

The AMR fellowship competition offered early-career and mid-career routes for UK-based researchers. Early-career awards supported up to two years; mid-career awards up to three years with an interdisciplinary secondment. Applications closed

EUCAST has established its Phage Susceptibility Testing (PST) Subcommittee to develop standardized methods for testing therapeutic phages. Frédéric Laurent is chair and Annika Classen is scientific secretary. EUCAST

The Novo Nordisk Foundation’s Challenge Programme 2027 supports early-stage proof-of-concept research on rapid, minimally invasive and affordable point-of-care tests for lower respiratory tract infections. Grants of DKK 30–75 million run fo

Tobi Nagel, Martha Clokie and Janet Nale on using phages to combat antimicrobial resistance through laboratory training workshops. Webinar; platform not established SBRT via Taruna Anand lab archive

The Phage Collection Project was a flagship exhibit at the Royal Society Summer Science Exhibition from July 1–6, 2025. Project lead Franklin and coordinator Esme presented how phages could tackle antibiotic resistance, and the team launche

ESCMID scheduled an in-person postgraduate course and hands-on phage-therapy workshop at Tbilisi State Medical University and the George Eliava Institute for May 11–13, 2026. The program included lectures, case discussions and laboratory wo